May 07, 2020
Syndax Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Clinical and Business Update
Nov 29, 2019
National Medical Products Administration (NMPA) Approves Chipscreen Bioscience's Chidamide (Epidaza) for Breast Cancer Indication
Nov 18, 2019
Alkermes to Acquire Rodin Therapeutics
Apr 26, 2019
Global HDAC (histone deacetylase) Inhibitors Market to 2023 Featuring Celgene, Merck & Co, Novartis, Shenzhen Chipscreen Biosciences, & Spectrum Pharmaceuticals
Mar 12, 2019
CStone received IND approval in China for HDAC6 inhibitor CS3003
Mar 07, 2019
Syndax Pharmaceuticals Reports Fourth Quarter 2018 Financial Results and Provides Clinical and Business Update
Aug 30, 2018
MEI Pharma Reports Fiscal Year 2018 Results and Operational Highlights
Aug 07, 2018
Syndax Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Clinical and Business Update
Aug 02, 2018
Investigator-initiated Phase II Clinical Study of Remetinostat Started in Patients With Basal Cell Carcinoma
Jun 21, 2018
GNTbm announces licensing of exclusive sales/marketing rights of anticancer drug Chidamide to Taiwan Specialty Pharma Corp. (TSPC)
Jun 18, 2018
Continued Discussions With FDA on Proposed Remetinostat Phase III Design Results in Delay in Planned Start of Study
Jun 15, 2018
MEI Pharma Presents Clinical Data on ME-401 at the European Hematology Association Congress
Jun 04, 2018
MEI Pharma Presents Phase 1b Clinical Data for ME-401 in Patients with Indolent B-Cell Malignancies at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 30, 2018
Syndax and Nektar Therapeutics Announce Immuno-Oncology Clinical Trial Collaboration
May 18, 2018
Additional Remetinostat Phase II Data Will be Presented at the International Investigative Dermatology Meeting on May 18 and 19
May 16, 2018
MEI Pharma to Present Clinical Data at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
May 09, 2018
MEI Pharma Reports Third Quarter Fiscal Year 2018 Results
May 08, 2018
Syndax Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Clinical and Business Update
May 02, 2018
OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug
Mar 05, 2018
Syndax Pharmaceuticals Reports Fourth Quarter 2017 Financial Results and Provides Clinical and Business Update